BRIEF published on 11/04/2024 at 11:51, 1 year 6 months ago Acticor Biotech : Publication des résultats financiers semestriels 2024 Résultats Semestriels Biotechnologie Finance Redressement Judiciaire Glenzocimab
BRIEF published on 11/04/2024 at 11:51, 1 year 6 months ago Acticor Biotech: Publication of 2024 half-year financial results Biotechnology Finance Half-year Results Glenzocimab Judicial Recovery
PRESS RELEASE published on 11/04/2024 at 11:46, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats Acticor Biotech publie ses résultats financiers semestriels 2024 et annonce le repositionnement du glenzocimab dans le traitement de l’infarctus du myocarde avec élévation du segment ST (STEMI) Résultats Financiers ACTICOR BIOTECH Glenzocimab Repositionnement Infarctus Du Myocarde
PRESS RELEASE published on 11/04/2024 at 11:46, 1 year 6 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its half-year financial results for 2024, highlighting repositioning of glenzocimab in STEMI treatment, receivership proceedings extension, and shareholder approvals Repositioning Shareholder Approvals ACTICOR BIOTECH Glenzocimab Half-year Financial Results
BRIEF published on 10/11/2024 at 17:50, 1 year 7 months ago Acticor Biotech Advances Glenzocimab in Myocardial Infarction Treatment Clinical Trials Myocardial Infarction ACTICOR BIOTECH Glenzocimab Cardiovascular Treatment
BRIEF published on 10/11/2024 at 17:50, 1 year 7 months ago Acticor Biotech fait progresser le Glenzocimab dans le traitement de l'infarctus du myocarde Essais Cliniques ACTICOR BIOTECH Glenzocimab Infarctus Du Myocarde Traitement Cardiovasculaire
PRESS RELEASE published on 10/11/2024 at 17:45, 1 year 7 months ago Inside Information / Other news releases Acticor Biotech repositions glenzocimab in the treatment of myocardial infarction, evaluating efficacy and safety in phase 2 studies LIBERATE and GLORIA. Clinical trials aim to reduce infarct size and prevent complications Clinical Trials Phase 2b Myocardial Infarction ACTICOR BIOTECH Glenzocimab
PRESS RELEASE published on 10/11/2024 at 17:45, 1 year 7 months ago Informations privilégiées / Autres communiqués Repositionnement de glenzocimab dans le traitement de l'infarctus du myocarde par Acticor Biotech. Nouvelle étude de phase 2b LIBERATE et préparation de l'étude GLORIA Traitement Étude Clinique ACTICOR BIOTECH Glenzocimab Infarctus Du Myocarde
BRIEF published on 07/09/2024 at 20:50, 1 year 10 months ago Acticor Biotech Reports 2023 Financial Results Financial Report Annual Results Capital Raising ACTICOR BIOTECH Glenzocimab
BRIEF published on 07/09/2024 at 20:50, 1 year 10 months ago Acticor Biotech publie ses résultats financiers pour 2023 Résultats Annuels Rapport Financier ACTICOR BIOTECH Glenzocimab Levée De Capitaux
Published on 05/29/2026 at 15:50, 5 hours 12 minutes ago Power Metallic Mines Announces Upsize of Brokered LIFE Offering for Gross Proceeds of up to C$30 Million
Published on 05/29/2026 at 14:30, 6 hours 32 minutes ago Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice
Published on 05/29/2026 at 14:30, 6 hours 32 minutes ago Unusual Machines to Participate in June Investor Conferences
Published on 05/29/2026 at 14:20, 6 hours 42 minutes ago Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
Published on 05/29/2026 at 13:59, 7 hours 3 minutes ago AIP Realty Trust Announces First Quarter 2026 Results
Published on 05/29/2026 at 20:00, 1 hour 2 minutes ago Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 1 hour 15 minutes ago CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 1 hour 34 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/29/2026 at 19:18, 1 hour 43 minutes ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Change to the shareholding structure
Published on 05/29/2026 at 18:50, 2 hours 12 minutes ago EQS-Adhoc: fox e-mobility AG: Capital Increase and Debt Reduction at Fox Automotive Switzerland AG – Adjustment of Shareholding Value – Departure of Philippe Perret – Financial Reports – Annual General Meeting D
Published on 05/29/2026 at 18:00, 3 hours 2 minutes ago Recticel Group versnelt groei in isolatiepanelen met geïntegreerde isothermische oplossingen na overname Isopanel NV
Published on 05/29/2026 at 18:00, 3 hours 2 minutes ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 15:38, 5 hours 24 minutes ago Déclaration d'actions et de droits de vote au 30.04.2026
